Hastra PRIME vs Injective Staking
Side-by-side comparison of PRIME and INJ staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Hastra PRIME vs Injective: which should you stake?
Injective currently offers the higher APY at 7.40% compared to Hastra PRIME's 4.00%. That's a 3.40 percentage point difference in annual yield.
In terms of market cap, Hastra PRIME is the larger asset at $512.74M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Hastra PRIME vs Injective — common questions
Is Hastra PRIME or Injective better for staking?
Injective currently offers a higher staking APY at 7.40% compared to Hastra PRIME's 4.00%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Hastra PRIME and Injective?
Hastra PRIME offers 4.00% APY while Injective offers 7.40% APY — a difference of 3.40 percentage points.
Which is safer to stake: PRIME or INJ?
Hastra PRIME has a medium risk rating while Injective has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both PRIME and INJ?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Hastra PRIME and Injective spreads your risk across different networks and protocols.